Both in Pharmaceuticals
Organon & vs Enliven Therapeutics
Over the past year OGN returned +106.9% and ELVN returned +107.8%; their daily moves had a correlation of 0.09.
OGN +106.9% ELVN +107.8%Growth of $1, one year, split-adjusted
| Metric | OGN | ELVN |
|---|---|---|
| Price | $13.78 | $44.78 |
| Market cap | $3.62B | $3.28B |
| Today | +0.22% | +2.49% |
| 1 month | +0.3% | −3.7% |
| 6 months | +3.3% | +5.6% |
| Year to date | +92.2% | +190.8% |
| 1 year | +95.2% | +109.3% |
| Revenue growth (YoY) | −2.3% | — |
| Gross margin | 54.4% | — |
| Net margin | 6.9% | — |
| P/E (TTM) | 17.3× | — |
| Price / sales | 0.6× | — |
| Net cash | -$7.42B | $895.2M |
| Dividend yield | 0.58% | — |
| Volatility (60d) | 2.9% | 40.2% |
| Short % of float | 7.2% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).